Abstract 13236: Elevated Serum Proprotein Convertase Subtilisin/Kexin Type 9 Level Independently Predicts Long-Term Cardiovascular Outcomes in Patients With Chronic Coronary Artery Disease

Aiko Sakamoto,Nobukazu Ishizaka,Masae Uehara,Jiro Ando,Issei Komuro

Abstract 13236: Elevated Serum Proprotein Convertase Subtilisin/Kexin Type 9 Level Independently Predicts Long-Term Cardiovascular Outcomes in Patients With Chronic Coronary Artery Disease

2016

Aiko Sakamoto
Nobukazu Ishizaka
Masae Uehara
Jiro Ando
Issei Komuro

Background: Proprotein convertase subtilisin/kexin type 9 (PCSK9) may directly promote atherosclerosis. However, the long-term impact of elevated serum PCSK9 levels on the risk of cardiovascular ev...

Keywords:

Internal medicine
Kexin
Biomarker (medicine)
PCSK9
Coronary artery disease
Subtilisin
Proprotein convertase
Medicine
Diabetes mellitus
Cardiology
elevated serum

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations